Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu
HB18-1330

Supplemental Payment Office-administered Drugs Medicaid

Concerning a supplemental state payment relating to certain office-administered oncology-related drugs for qualified providers under the medical assistance program who experienced a reduction in reimbursement payments in the 2017-18 state fiscal year as a result of the implementation of the federal final rules for covered outpatient drugs, and, in connection therewith, making an appropriation.
Session:
2018 Regular Session
Subject:
Health Care & Health Insurance
Bill Summary

Joint Budget Committee. The bill authorizes a supplemental payment of state-only money to providers under the medicaid program of certain office-administered drugs relating to oncology who experienced a decrease in aggregate reimbursements in the 2017-18 fiscal year as a result of the implementation of the federal department of health and human services final rule for covered outpatient drugs, 81 FR 5169, published in the federal register on February 1, 2016.

The bill directs the department of health care policy and financing (department) to distribute a supplemental payment to qualified providers, as defined in the bill, and includes provisions for determining the amount of each qualified provider's supplemental payment. The bill authorizes the medical services board to adopt rules as necessary.

The bill appropriates general fund money to the department for the supplemental payment to qualified providers.


(Note: This summary applies to the reengrossed version of this bill as introduced in the second house.)

,

Status

Introduced
Passed
Became Law

Bill Text

  • All Versions (7 )
    Date Bill Type Documents
    04/23/2018 Signed Act PDF
    04/16/2018 Final Act PDF
    04/05/2018 Rerevised PDF
    04/04/2018 Revised PDF
    03/29/2018 Reengrossed PDF
    03/28/2018 Engrossed PDF
    03/26/2018 Introduced PDF